Delivery Order SPE2DX22D0010-SPE2D826FBN61
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Methylphenidate ER (extended-release) brand-name tablets at 72mg strength. This firm fixed-price delivery order is valued at $6,334.55 with an ultimate completion date of November 3, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,069.62. This firm fixed price delivery order, with an ultimate completion date of November 13, 2025, was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Methylphenidate ER Tablets 18mg under a firm fixed-price contract valued at $3,505.40, with completion required by December 1, 2025. This non-set-aside competitive award will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,860.55. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for methylphenidate ER 27 mg tablets (100 count) with a ceiling value of $1,851.44. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This competitive award carries a ceiling value of $2,436.12 with firm fixed pricing and is scheduled for completion by July 21, 2025. The contract was not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36mg tablets (100-count) with a ceiling value of $5,179.68. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of the same day. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100, with a contract ceiling value of $1,224.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units. This competitive award, valued at $1,108.74, represents a firm fixed-price delivery order with an ultimate completion date of November 7, 2025. The contract was issued with no set-aside designation, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBN61Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Methylphenidate ER tablets in 36-milligram dosage. This is a firm fixed-price delivery order with a ceiling value of $3,312.60 and an ultimate completion date of December 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp's federal procurement portfolio demonstrates extensive capability in fulfilling pharmaceutical needs across multiple therapeutic domains, including neurological, pain management, and infectious disease treatments, supporting critical medical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/4/25 |